期刊文献+

非毒性结节性甲状腺肿和孤立性结节患者甲状腺乳头状癌风险比较 被引量:2

Comparing the risk of papillary thyroid carcinoma between patients with nontoxic multinodular goiter and solitary nodule
原文传递
导出
摘要 比较非毒性结节性甲状腺肿(nontoxicmultinodulargoiter,MNG)和孤立性甲状腺结节(solitarynodule,SN)患者甲状腺乳头状癌(papillarythyroidcarcinoma,PTC)发生率。761例在本院进行甲状腺手术的患者根据病理学诊断结果分为两组,MNG组和sN组。MNG组患者PTC发生率显著低于sN组患者(7.09%对15.58%,P=O.0009)。非毒性结节性甲状腺肿患者PTC发生率显著低于孤立性结节患者。 To investigate the risk of "papillary thyroid carcinoma (PTC) in patients with nontoxic muhinodular goiter (MNG) compared to that in patients with solitary nodule (SN). From Jan 2006 to Dec 2011,761 patients underwent thyroid surgery were included in the retrospective study. According to pathology, patients were subdivided into two groups, MNG and SN. Preoperative thyroid profiles were correlated with patients' postoperative diagnoses. In whole group, the risk of PTC was significantly lower in MNG than in SN (7.09% vs 15.58% , P = 0. 000 9 ). In patients with nontoxic multinodular goiter, the risk of PTC was lower compared to that of those with SN.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第12期1015-1017,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺乳头状癌 甲状腺结节 Papillary thyroid carcinoma Thyroid nodules
  • 相关文献

参考文献27

  • 1International Agency for Research on Cancer. Launch of Globocan, 2008,2010. http://globocan.iarc.fr/.
  • 2National Cancer Institute. Surveillance Epidemiology and End Results (SEER): Cancer Statistic Review 1975-2009. 2012. National Institutes of Health: www.cancer.gov.
  • 3Pelizzo MR, Bernante P, Toniato A, et al. Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori, 1997,83:653-655.
  • 4Tezelman S, Borucu I, Senyurek Giles Y, et al. The change in surgical practice from subtotal to near-total or tatal thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg, 2009,33:400-405.
  • 5Lasithiotakis K, Grisbolaki E, Koutsomanolis D, et al. Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter. World J Surg, 2012,36:1286-1292.
  • 6Luo J, McManus C, Chen H, et al. Are there predictors of malignancy in patients with multinodular goiter? J Surg Res, 2012,174:207-210.
  • 7Rios A , Rodriguez JM , Canteras M, et al. Risk factors for malignancy in multinodular goiters. Eur J Surg Oncol, 2004,30:58-62.
  • 8Botrugno I, Lovisetto F, Cobianchi L, et al. Incidental carcinoma in multinodular goiter: risk factors. Am Surg, 2011,77:1552-1558.
  • 9Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab, 2002,87:1941-1946.
  • 10Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med, 2000,1339:696-700.

二级参考文献61

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2武晓泓,陆晓婕,刘超,狄福松,何戎华,蒋须勤.甲状腺偶发结节的筛查及随访[J].中国实用内科杂志,2005,25(9):823-824. 被引量:30
  • 3冯尚勇,刘超,刘晓云,段宇,刘翠萍.江苏高淳、楚州地区社区人群甲状腺结节流行特征研究[J].南京医科大学学报(自然科学版),2006,26(8):717-720. 被引量:66
  • 4Gomez Saez JM. Diagnostic and prognostic markers in differentiated thyroid cancer. Curr Genomics, 2011,12:597-608.
  • 5Kouniavsky G, Zeiger MA. The quest for diagnostic molecular markers for thyroid nodules with indeterminate ar suspicious cytology. J Surg Oncol, 2012,105:438-443.
  • 6Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol, 2011,5:51-56.
  • 7Marchetti I, Iervasi G, Mazzanti CM, et al. Detection of the BRAF (V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection : an easy tool to improve the preoperative diagnosis. Thyroid, 2012,22:292-298.
  • 8Nikiforov YE. Molecular analysis of thyroid tumors. Mod Pathol, 2011, 24 ( Suppl 2 ) : S34-S43.
  • 9Yu S, Liu Y, Wang J, et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab, 2012,97:2084-2092.
  • 10YaoZ, Yin P, Su D, et al. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Mol Biosyst, 2011,7 : 2608 -2614.

共引文献862

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部